B1 - Transition of Care (Inbound -Reject/Timeout Inbound CCD)Test 10, 11, 13, 22 missing from new ETT portal

[BK]

Hello Team,

we observed that in the new portal  one test case missing - B1 - Transition of Care (Inbound -Reject/Timeout Inbound CCD)Test 10, 11, 13, 22 missing from new ETT portal

Portal : https://site.healthit.gov/direct/testbycriteria/B1

Could you confirm if this something missed in the new portal or this test is no longer needed to validate part of B1 - Inbound test scenario. 

Thanks

Bheem

[Kim Poletti]

Hi - Thanks for reaching out. This has been logged for review and a member of the team will reach out in the near future.

[James Spillman]

Can you please clarify which test procedure you are referring to? Those tests are not listed in the test procedure document for B1

https://www.healthit.gov/test-method/transitions-care#test_procedure

Do you recall where you saw these tests in ETT previously?

[BK]

here is the screenshot from previous version of ETT. Please let us know if this is still  valid test or can be removed from the list? thanks

[Kim Poletti]

Thank you. The team will review this and get back to you.

[Katie Crenshaw]

Hello all, I reviewed archived versions of the (b)(1) test procedure and found a note in the revision history on April 24, 2017 that SMTP Test 10, 11 and 13 were removed as test cases in (b)(1) to reduce the burden of Edge Testing. They also note the removal of "Negative test steps SMTP Test 22". I've attached the archived test procedure for your records. This update occurred at v1.9 which begins on pg. 9, but the language is on pg. 10. 

Excerpt of the relevant revision history:
"Removed the following test cases to reduce the burden of Edge Testing: XDR MT Test 19, XDR MT Test 48, XDR MT Test 50a and 50b, SMTP MT Test 17, SMTP MT Test 18, SMTP Test 47 and Test 47a, SMTP Test 10, SMTP Test 11, SMTP Test 13. Removed Negative connection test steps SMTP Test 22, documentation of negative authentication due to an invalid DIGEST-MD5 value."

[James Spillman]

Locking this conversation. If you have further questions please start a new conversation.